Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Oct. 9, 2026. Document 2026-20757. Updated Nov. 5, 2026.
- What it does
The Drug Enforcement Administration (DEA) is revoking the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products, but whose National Drug Codes (NDC) are inactive because they are no longer available and/or the company that applied for the exemption no longer exists. These products will be removed from DEA's Table of Exempted Prescription Products and will no longer be considered exempt prescription products under the Controlled Substances Act. This action does not impact exempted prescription products with active NDC numbers.
The Drug Enforcement Administration's summary, as published in the Federal Register.
- What changed in the regulation
1 part of Title 21 of the Code of Federal Regulations:
- Compared with
The Drug Enforcement Administration has published 25 final rules in 2026 so far, compared with 17 in all of 2025.
Counted by the Tribune from Federal Register records since Jan. 1, 2025.
- Before this
1 earlier Federal Register document under regulation identifier 1117-ZA08 since Jan. 1, 2025.
- What happens next and when
This final determination is effective on November 9, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2026-20757 |
|---|---|
| Action | Final determination. |
| Agencies | Justice Department; Drug Enforcement Administration |
| Published | Oct. 9, 2026 |
| Effective date | Nov. 9, 2026 |
| Regulation identifier (RIN) | 1117-ZA08 |
| Docket | DEA-2026-0893 |
Source: the Federal Register (public domain). The document in the Federal Register